BearingPoint Study Unveils Three Steps for Enhanced Welfare Services
1.8.2023 09:55:00 EEST | Business Wire | Press release
Management and technology consultancy BearingPoint has released its latest study, “Digital delivery holds the key for enabling better welfare services,” which examines the digital maturity of social welfare services across ten countries in Europe, North America, and Asia-Pacific. The study assesses the state of various social welfare programs, focusing on core industry digital dimensions and social protection categories, and highlights how governments are leveraging digital transformation to meet evolving socio-economic needs and introducing innovative solutions. The study identifies three crucial steps for government ministries and agencies responsible for social welfare services to enhance well-being outcomes for citizens:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230801342246/en/
• Reorient social welfare services around citizen segments and specific needs
• Rethink how to deliver true change and transformation in the delivery of services
• Realize tangible social and economic benefits for both public servants and citizens
This study explores why these actions are necessary, outlining what government leaders must do now and the anticipated benefits and outcomes.
Andrew Montgomery, Global Leader Government and Public Sector at BearingPoint, states: “Social welfare services form a significant part of annual expenditure for all governments, both in terms of citizen payments and service delivery costs. Our research and client experience highlights how digital and innovative technologies can improve the alignment of services with citizen needs, enable quicker responses to changing socio-economic conditions and ensure effective allocation of social welfare budgets.”
The global social welfare digital services leaders
As social welfare is a vast domain with many evolving digital developments, a simple, single-dimension maturity model would not provide any meaningful insight. Therefore, the study’s approach was multi-dimensional, examining the global digital service maturity of social welfare benefits across four digital dimensions and six social welfare categories. Of the ten countries assessed for their achievements in digitalizing access to social welfare services, the research shows that countries like Singapore, France, and Canada are typically at a higher level of digital maturity than others and offer leading practice examples. Singapore was the most digitally mature globally.
Countries were assessed on a score from 1-5 across four of the OECD’s Digital Dimensions (Digital by Design, User Driven, Government as a Platform, and Proactiveness) and the EU/EEA’s MISSOC Social Protection Categories (Unemployment, Health, Incapacity, Old-Age & Survivors, Family, and Social Assistance).
Digital by Design was the strongest dimension, with all countries optimized for digital applications and achieving an average score of 3.9 out of 5 across all categories. Proactiveness was the lowest scoring dimension across all categories, with an average aggregate score of 3.1, with opportunities identified for websites to include proactive prompts or auto-enrolment functionality.
Digital maturity in Unemployment is the strongest scoring (81%) and Incapacity (64%) the lowest in the MISSOC Social Protection Categories (Unemployment, Health, Incapacity, Old-Age & Survivors, Family, and Social Assistance).
About the study
The study examines the global digital service maturity of social welfare benefits across ten countries (Canada, Denmark, Estonia, France, Germany, Ireland, New Zealand, Norway, Singapore, and the UK), four digital dimensions, and six social welfare categories. It was based on desk-based research and validated with local contacts.
Download the study to find out more: https://www.bearingpoint.com/en/insights-events/insights/digital-strategy-for-citizens-well-being/
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230801342246/en/
Contact information
Alexander Bock
Global Senior Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
